INFI - Infinity Pharmaceuticals Inc. (INFI) CEO Adelene Perkins on Q1 2022 Results - Earnings Call Transcript
Infinity Pharmaceuticals, Inc. (INFI) Q1 2022 Earnings Conference Call May 03, 2022, 04:30 AM ET Company Participants Jayne Kauffman - Senior Executive Coordinator Adelene Perkins - Chairman and CEO Robert Ilaria - Chief Medical Officer Larry Bloch - President Conference Call Participants Anupam Rama - JPMorgan Nick Abbott - Wells Fargo Soumit Roy - Jones Research Presentation Operator Ladies and gentlemen, thank you for standing by. Welcome to the Infinity Pharmaceuticals Conference Call to discuss the company's operations and First Quarter 2022 Financial Results. My name is Sarah, and I'll be your operator for today's call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at Infinity's request. Now I would like to introduce your host for today's call, Jayne Kauffman. Please go ahead. Jayne Kauffman Thank you Sarah, and good afternoon
For further details see:
Infinity Pharmaceuticals, Inc. (INFI) CEO Adelene Perkins on Q1 2022 Results - Earnings Call Transcript